Publications by authors named "Kerem Ozer"

Claim this Profile
E
Embracing Generative Artificial Intelligence in Clinical Research and Beyond: Opportunities, Challenges, and Solutions.
Henry P Foote, Chuan Hong, Mohd Anwar, Maria Borentain, Kevin Bugin, Kerem Ozer

JACC Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aquacel Ag Advantage/Ag+ Extra and Cutimed Sorbact in the management of hard-to-heal wounds: a cohort study.
Joachim Dissemond, Kristina Aare, Kerem Ozer, Divay Gandhi, Jessica L Ryan

J Wound Care· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Infusion Set Materials and Designs on the Subcutaneous Response in People With Diabetes: A Rapid Review of the Literature.
Kristoffer Hendel, Tobias Stumpe, Kerem Ozer

J Diabetes Sci Technol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis.
Anders L Carlson, Timothy Dilon Daniel, Andrea DeSantis, Serge Jabbour, Esra Karslioglu French, Kerem Ozer

BMJ Open Diabetes Res Care· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study.
Kerem Ozer, Alison M Cooper, Lily P Ahn, Cassidy R Waggonner, Thomas C Blevins

Diabetes Technol Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telemedicine During the COVID-19 Crisis and Beyond.
Thomas Blevins, Kerem Ozer

Tex Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trial.
Lowell R Schmeltz, Thomas C Blevins, Stephen L Aronoff, Kerem Ozer, Jonathan D Leffert

J Clin Endocrinol Metab· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.
Barbara M Brooks-Worrell, Dinakar Iyer, Ivonne Coraza, Christiane S Hampe, Ramaswami Nalini, Kerem Ozer

Diabetes Care· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of patients with ketosis-prone diabetes (KPD) presenting with acute pancreatitis: implications for the natural history and etiology of a KPD subgroup.
Ramiro Fernandez, Ranjita Misra, Ramaswami Nalini, Christiane S Hampe, Kerem Ozer

Endocr Pract· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenesis of A⁻β⁺ ketosis-prone diabetes.
Sanjeet G Patel, Jean W Hsu, Farook Jahoor, Ivonne Coraza, James R Bain, Kerem Ozer

Diabetes· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery: comment on Isbell et al.
Kerem Ozer, Shadi Abdelnour, Ajjai S Alva

Diabetes Care· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-β+" ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection.
Ramaswami Nalini, Kerem Ozer, Mario Maldonado, Sanjeet G Patel, Christiane S Hampe

Metabolism· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice.
Vijay Yechoor, Victoria Liu, Antoni Paul, Jeongkyung Lee, Eric Buras, Kerem Ozer

Endocrinology· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical coherence tomography and its use in detection of vulnerable plaque.
Mehmet Cilingiroglu, Kerem Ozer

Curr Atheroscler Rep· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis.
Mehmet Cilingiroglu, Kerem Ozer

Curr Atheroscler Rep· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vulnerable plaque: definition, detection, treatment, and future implications.
Kerem Ozer, Mehmet Cilingiroglu

Curr Atheroscler Rep· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis